About
Jasper Levink is a Dutch biotech executive and entrepreneur currently serving as CEO of Khondrion, a clinical-stage company developing therapies for primary mitochondrial disease. Khondrion states that he previously served as Partner and Managing Director at ttopstart and held business-development roles including CBO at LenioBio. Public sources consistently position him as a life-sciences operator and commercialization strategist rather than an investor or fund manager.
Areas of interest
biotechlife sciencesmitochondrial diseaserare disease therapeuticsbusiness developmentbiopharma financecommercialization strategyEU-funded health innovationscience-to-business translation